Britannica
Sources used in this answer
How could biomarkers help detect pancreatic cancer earlier?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
pancreatic cancer
The human pancreas is composed of two main types of tissue: acinar cells and islets of Langerhans. The acinar cells produce digestive enzymes, which are secreted into tiny ducts that feed into the pancreatic duct. Islets of Langerhans are clusters of cells that secrete hormones such as insulin and glucagon directly into a capillary network, which also joins the pancreatic duct.
Early detection of pancreatic cancer is critical for improving patient survival rates, as symptoms often remain hidden until the disease reaches an advanced stage. Research into biomarkersāmeasurable biological indicators such as proteins or genetic mutationsāoffers a promising path toward identifying the disease at its earliest, most treatable stages.12
Biomarkers help detect pancreatic cancer in several ways:
- Identifying Precancerous Lesions: Scientists are focusing on detecting subtle molecular changes that serve as indicators of precancerous pancreatic lesions.1
- Minimally Invasive Screening: New technologies, such as light-scattering spectroscopy used with endoscopes, allow doctors to detect specific biomarkers in the duodenum. This method is significantly less invasive than traditional needle biopsies, which carry risks of complications like pancreatitis.1
- Pattern Analysis: Because individual biomarkers can be nonspecific, researchers use proteomics and computational methods to analyze patterns of multiple proteins. By superimposing these expression profiles, clinicians can more accurately distinguish between disease and disease-free states.2
By enabling earlier diagnosis, these molecular tools aim to shift the prognosis for patients, as survival rates are notably higher when the cancer is identified before it has spread.1